±Û·Î¹ú ¾È°æ·»Áî Àü¹® ±â¾÷ ¿¡½Ç·ÎÄÚ¸®¾Æ°¡ µðÁöÅРȯ°æ ¼Ó ¾î¸°ÀÌ ´« °Ç° º¸È£¸¦ À§ÇØ ±Ù½Ã ÁøÇà ¾ïÁ¦ ¾È°æ·»Áî ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®(Essilor Stellest)’¿Í ÇÁ¸®¹Ì¾ö ÄÚÆÃ ‘Å©¸®Àß ÇÁ¸®º¥½Ã¾Æ(Crizal Prevencia)’¸¦ ÇÔ²² Á¦¾ÈÇϸç, ±Ù½Ã ¾ïÁ¦¿Í ºí·ç¶óÀÌÆ® ÇÊÅ͸µÀ» µ¿½Ã¿¡ °æÇèÇÒ ¼ö ÀÖ´Â ¾÷±×·¹À̵å À̺¥Æ®¸¦ Àü°³ÇÑ´Ù.
ÃÖ±Ù µðÁöÅÐ ÇнÀ°ú ½º¸¶Æ® ±â±â »ç¿ëÀÌ ÀÏ»óÈµÇ¸ç ¾î¸°À̵éÀÇ ºí·ç¶óÀÌÆ® ³ëÃ⠽ð£ÀÌ ±ÞÁõÇϰí ÀÖ´Ù. ºí·ç¶óÀÌÆ®´Â 380~500nm ÆÄÀåÀÇ ÆÄ¶õ»ö °è¿ °¡½Ã±¤¼±À¸·Î, ƯÈ÷ 415~455nm ´ë¿ªÀº ´«ÀÇ ÇǷθ¦ À¯¹ßÇÏ°í ¼ö¸é ÆÐÅÏÀ» ¹æÇØÇÏ´Â µî ½Ã·Â°ú °Ç°¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù.[1]
ÀÌ¿¡ ¿¡½Ç·ÎÄÚ¸®¾Æ´Â 9¿ù 15ÀϱîÁö ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®’ ±¸¸Å °í°´¿¡°Ô ºí·ç¶óÀÌÆ® ÇÊÅÍ ±â´ÉÀ» °®Ãá ‘Å©¸®Àß ÇÁ¸®º¥½Ã¾Æ’ ÄÚÆÃ ¹«·á ¾÷±×·¹À̵å ÇýÅÃÀ» Á¦°øÇÑ´Ù. ‘Å©¸®Àß ÇÁ¸®º¥½Ã¾Æ’ ÄÚÆÃÀº °íµµÈµÈ ÇÊÅÍ ±â¼úÀ» Àû¿ëÇØ À¯ÇØÇÑ ºí·ç¶óÀÌÆ®¿Í Àڿܼ±Àº È¿°úÀûÀ¸·Î ÇÊÅ͸µÇϰí, ÇÊ¿äÇÑ °¡½Ã±¤¼±Àº ±×´ë·Î Åë°ú½ÃÄÑ Àå½Ã°£ µðÁöÅÐ ±â±â »ç¿ë ½Ã¿¡µµ ´«ÀÇ ºÎ´ãÀ» ´ú¾îÁØ´Ù.[2]
‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®’´Â ±Ù½Ã ±³Á¤°ú ¾ïÁ¦¸¦ ÇÑ ¹ø¿¡ ÇÒ ¼ö ÀÖ´Â ¾È°æ·»Áî·Î, ¸ÅÀÏ 12½Ã°£ Âø¿ë ½Ã ±Ù½Ã ÁøÇàÀ» 67% ¾ïÁ¦ÇÑ´Ù.[3] ·»Áî Ç¥¸éÀÇ 40%¿¡ 1021°³ÀÇ ¸¶ÀÌÅ©·Î·»Áî°¡ 11°³ÀÇ ¸µ ÇüÅ·Π¹èÄ¡µÅ ±Ù½Ã¸¦ ¾ïÁ¦Çϸ鼵µ ´ÜÃÊÁ¡ ¾È°æ·»Áî °°Àº ¼±¸íÇÑ ½Ã¾ß¸¦ Á¦°øÇÑ´Ù.[4]
¿¡½Ç·ÎÄÚ¸®¾ÆÀÇ °¹ÎÁö ½ºÅÚ¸®½ºÆ® Á¦Ç° ´ã´ç Â÷ÀåÀº “¹æÇÐ Áß µðÁöÅÐ ±â±â »ç¿ë ½Ã°£ÀÌ ±æ¾îÁø ¾ÆÀ̵éÀº ±Ù½Ã»Ó¸¸ ¾Æ´Ï¶ó ºí·ç¶óÀÌÆ® ³ëÃâ µî º¹ÇÕÀûÀÎ ¿ä¼Ò¸¦ °í·ÁÇÑ ´« °Ç° °ü¸®°¡ ²À ÇÊ¿äÇÏ´Ù”¸ç “À̹ø À̺¥Æ®¸¦ ÅëÇØ »õÇбâ Àü ÀÚ³àÀÇ ´« °Ç°À» Á¡°ËÇÏ°í ¸ÂÃãÇü ½Ã·Â °ü¸®¸¦ ½ÃÀÛÇÏ±æ ¹Ù¶õ´Ù”°í ¸»Çß´Ù.
ÇÑÆí ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®’¸¦ Ãë±ÞÇÏ´Â °¡±î¿î ¾È°æ¿øÀº Àü¿ë À¥»çÀÌÆ®(
https://stellest.co.kr)¿¡¼ °Ë»öÇÒ ¼ö ÀÖÀ¸¸ç, Á¦Ç°¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸´Â °ø½Ä ȨÆäÀÌÁö(
https://www.essilor.com/kr-ko)¿Í ½ºÅÚ¸®½ºÆ® °ø½Ä ºí·Î±×(
https://blog.naver.com/essilor_stellest)¿¡¼ È®ÀÎ °¡´ÉÇÏ´Ù.
[1] ‘Effects of blue light blocking glasses on visual fatigue and performance.’ (Hirakawa, Y., et al., 2017). Optometry and Vision Science.
[2] Within Crizal® Range - External laboratories tests and internal technical tests in 2019 - compared to all previous generations of Crizal® coatings
[3] Áß±¹ ¿øÀú¿ì¿¡¼ ¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®¸¦ Âø¿ëÇÑ ±Ù½Ã ¾î¸°ÀÌ 54¸í°ú ¿¡½Ç·Î ·è¼ÒƼī ´ÜÃÊÁ¡ ·»Á Âø¿ëÇÑ ±Ù½Ã ¾î¸°ÀÌ 50¸íÀ» ´ë»óÀ¸·Î ÇÑ 2³â°£ÀÇ ÀüÇâÀû, ´ëÁ¶±ºÀÌ ÀÖ´Â, ¹«ÀÛÀ§ ¹èÁ¤, ÀÌÁß¸Í°Ë ÀÓ»ó½ÃÇè °á°ú. 32¸íÀÇ ¾î¸°À̵éÀÌ ¿¬¼Ó 2³â µ¿¾È ¸ÅÀÏ ÃÖ¼Ò 12½Ã°£ ¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®¸¦ Âø¿ë½Ã. Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, Wang C, Li Y, Lim EW, Spiegel DP, Drobe B, Chen, H. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA ophthalmology. 2022;140(5):472-8. doi:10.1001/jamaophthalmol.2022.0401
[4] Two-year prospective, controlled, randomized, double-masked clinical trial results on 54 myopic children wearing Stellest® lenses compared to 50 myopic children wearing single vision lenses. Results based on 32 children who declared wearing Stellest® lenses at least 12 hours per day every day. Bao, J. et al. (2021). One-year myopia control efficacy of spectacle lenses with aspherical lenslets. Br. J. Ophthalmol. doi:10.1136/bjophthalmol-2020-318367.